Total Funding
60
50
Total FundingGrant raised
Growth Score 60 in past quarter
-8 pts
Heat Score 50 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
231129
EIO Biomedical is an innovative biotechnology company developing a medical device for the prevention of post-surgical adhesions.
- Yair Pilpel: Founder and CEO
- Rafael Miller: CMO
About the Company
EIO Biomedical is an innovative biotechnology company developing a medical device for the prevention of post-surgical adhesions. EIO Biomedical is an NGT3 VC portfolio company established in 2016.
Located in Nazareth, Israel, the company secured financing of 3M NIS from NGT3 VC (www.ngt3vc.com ) and the Israeli Office of Chief Scientist (OCS).